Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $264000.0.

  • Jaguar Health's Change in Receivables rose 62800.0% to $264000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$394000.0, marking a year-over-year increase of 6641.09%. This contributed to the annual value of -$440000.0 for FY2024, which is 1398.96% down from last year.
  • Jaguar Health's Change in Receivables amounted to $264000.0 in Q3 2025, which was up 62800.0% from -$50000.0 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Change in Receivables registered a high of $1.4 million during Q1 2021, and its lowest value of -$2.0 million during Q3 2021.
  • For the 5-year period, Jaguar Health's Change in Receivables averaged around -$183578.9, with its median value being -$50000.0 (2024).
  • In the last 5 years, Jaguar Health's Change in Receivables tumbled by 86239.32% in 2023 and then skyrocketed by 79677.42% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Change in Receivables stood at -$402000.0 in 2021, then soared by 78.86% to -$85000.0 in 2022, then surged by 136.47% to $31000.0 in 2023, then soared by 796.77% to $278000.0 in 2024, then fell by 5.04% to $264000.0 in 2025.
  • Its last three reported values are $264000.0 in Q3 2025, -$50000.0 for Q2 2025, and -$304000.0 during Q1 2025.